2-巴豆酰辅酶A 锂盐
2-Butenoyl coenzyme A lithium 是一种灭活剂和恶性疟原虫烯酰基-β-羟酰基-酰基载体蛋白 (ACP) 还原酶和其他烯酰基-CoA 还原酶的底物，同时也是反式-2-甲基-2-丁烯酰辅酶 A 锂盐。2-Butenoyl coenzyme A lithium 作用于短链、中链辅酶 A 脱氢酶以及戊二酰辅酶 A 脱氢酶，对野生型异戊酰辅酶 A 脱氢酶无活性。2-Butenoyl coenzyme A lithium 在 L-异亮氨酸分解代谢通路中作为代谢物发挥作用，同时可作为 3-氧硫解酶活性检测实验的底物。2-Butenoyl coenzyme A lithium 可用于 3-氧硫解酶缺乏症的相关研究。
Physalin A 是一种具有生物活性的醉茄内酯。Physalin A 在椎间盘退变模型中表现出抗炎、抗纤维化和改善自噬 (autophagy) 的作用。Physalin A 具有抗肿瘤活性，可诱导细胞凋亡 (apoptosis)，ROS 产生和 G2/M 期细胞周期阻滞。此外。Physalin A 可显著提高醌还原酶活性，来提高解毒酶的表达。
地骨皮甲素
Kukoamine A 是一种具有口服活性可穿透血脑屏障的精胺类生物碱，被发现存在于宁夏枸杞 (Lycium chinense，L. chinense) Miller 的根皮中。Kukoamine A 可抑制纯化的簇生锥虫锥虫硫醇还原酶和大豆脂氧合酶 (lipoxygenase)，并激活 μ-阿片 (μ-opioid) 受体。Kukoamine A 能够抑制癌细胞增殖、迁移和侵袭，引起 G0/G1 期细胞周期阻滞并诱导细胞凋亡 (apoptosis)。Kukoamine A 具有神经保护作用，还可诱导自噬 (autophagy)。Kukoamine A 可抑制 LPS (HY-D1056) 诱导的 NO、ROS、PGE2、TNF-α、IL-1β、IL-6 的产生以及 COX-2 的活性。Kukoamine A 可通过下调 Srebp-1c 逆转棕榈酸诱导胰岛素抵抗、脂质蓄积和氧化应激。Kukoamine A 可用于癌症、感染、炎症、代谢性疾病和神经系统疾病的研究，例如胶质母细胞瘤和帕金森病。
莱苞迪苷D
Rebaudioside D 是一种口服有效的甜味剂，靶向激活 FXR、调节 Acetyl-CoA Carboxylase 和抑制 3-hydroxy-3-methylglutaryl-CoA reductase。Rebaudioside D 调控胆汁酸稳态与脂质代谢，降低脂肪酸与胆固醇的合成速率，具有抗脂肪生成、保肝、抗脂肪变性、调节肠道菌群、增强次级胆汁酸代谢、抗内毒素、调控胆汁酸转运及抑制胆汁酸外排等多重作用。Rebaudioside D 还减少体重增长、内脏脂肪堆积、肝脏甘油三酯与胆固醇蓄积、肝脏脂质过氧化，并降低循环中脂多糖结合蛋白的水平。Rebaudioside D 还增强肠道细菌次级胆汁酸代谢通路，上调回肠有机溶质转运蛋白 α 的基因表达，下调肝脏胆盐输出泵蛋白的基因表达。Rebaudioside D 不影响葡萄糖稳态、改变总热量摄入或粪便能量排泄、诱导体重增加、加重肥胖、促进肝脏脂肪变性、损伤棕色脂肪组织功能，也不会改变骨骼肌代谢相关蛋白。Rebaudioside D 可用于饮食诱导肥胖及肥胖相关研究。
2-巴豆酰辅酶A 锂盐
2-Butenoyl coenzyme A lithium 是一种灭活剂和恶性疟原虫烯酰基-β-羟酰基-酰基载体蛋白 (ACP) 还原酶和其他烯酰基-CoA 还原酶的底物，同时也是反式-2-甲基-2-丁烯酰辅酶 A 锂盐。2-Butenoyl coenzyme A lithium 作用于短链、中链辅酶 A 脱氢酶以及戊二酰辅酶 A 脱氢酶，对野生型异戊酰辅酶 A 脱氢酶无活性。2-Butenoyl coenzyme A lithium 在 L-异亮氨酸分解代谢通路中作为代谢物发挥作用，同时可作为 3-氧硫解酶活性检测实验的底物。2-Butenoyl coenzyme A lithium 可用于 3-氧硫解酶缺乏症的相关研究。
地骨皮甲素
Kukoamine A 是一种具有口服活性可穿透血脑屏障的精胺类生物碱，被发现存在于宁夏枸杞 (Lycium chinense，L. chinense) Miller 的根皮中。Kukoamine A 可抑制纯化的簇生锥虫锥虫硫醇还原酶和大豆脂氧合酶 (lipoxygenase)，并激活 μ-阿片 (μ-opioid) 受体。Kukoamine A 能够抑制癌细胞增殖、迁移和侵袭，引起 G0/G1 期细胞周期阻滞并诱导细胞凋亡 (apoptosis)。Kukoamine A 具有神经保护作用，还可诱导自噬 (autophagy)。Kukoamine A 可抑制 LPS (HY-D1056) 诱导的 NO、ROS、PGE2、TNF-α、IL-1β、IL-6 的产生以及 COX-2 的活性。Kukoamine A 可通过下调 Srebp-1c 逆转棕榈酸诱导胰岛素抵抗、脂质蓄积和氧化应激。Kukoamine A 可用于癌症、感染、炎症、代谢性疾病和神经系统疾病的研究，例如胶质母细胞瘤和帕金森病。
莱苞迪苷D
Rebaudioside D 是一种口服有效的甜味剂，靶向激活 FXR、调节 Acetyl-CoA Carboxylase 和抑制 3-hydroxy-3-methylglutaryl-CoA reductase。Rebaudioside D 调控胆汁酸稳态与脂质代谢，降低脂肪酸与胆固醇的合成速率，具有抗脂肪生成、保肝、抗脂肪变性、调节肠道菌群、增强次级胆汁酸代谢、抗内毒素、调控胆汁酸转运及抑制胆汁酸外排等多重作用。Rebaudioside D 还减少体重增长、内脏脂肪堆积、肝脏甘油三酯与胆固醇蓄积、肝脏脂质过氧化，并降低循环中脂多糖结合蛋白的水平。Rebaudioside D 还增强肠道细菌次级胆汁酸代谢通路，上调回肠有机溶质转运蛋白 α 的基因表达，下调肝脏胆盐输出泵蛋白的基因表达。Rebaudioside D 不影响葡萄糖稳态、改变总热量摄入或粪便能量排泄、诱导体重增加、加重肥胖、促进肝脏脂肪变性、损伤棕色脂肪组织功能，也不会改变骨骼肌代谢相关蛋白。Rebaudioside D 可用于饮食诱导肥胖及肥胖相关研究。
2-巴豆酰辅酶A 锂盐
2-Butenoyl coenzyme A lithium 是一种灭活剂和恶性疟原虫烯酰基-β-羟酰基-酰基载体蛋白 (ACP) 还原酶和其他烯酰基-CoA 还原酶的底物，同时也是反式-2-甲基-2-丁烯酰辅酶 A 锂盐。2-Butenoyl coenzyme A lithium 作用于短链、中链辅酶 A 脱氢酶以及戊二酰辅酶 A 脱氢酶，对野生型异戊酰辅酶 A 脱氢酶无活性。2-Butenoyl coenzyme A lithium 在 L-异亮氨酸分解代谢通路中作为代谢物发挥作用，同时可作为 3-氧硫解酶活性检测实验的底物。2-Butenoyl coenzyme A lithium 可用于 3-氧硫解酶缺乏症的相关研究。
Physalin A 是一种具有生物活性的醉茄内酯。Physalin A 在椎间盘退变模型中表现出抗炎、抗纤维化和改善自噬 (autophagy) 的作用。Physalin A 具有抗肿瘤活性，可诱导细胞凋亡 (apoptosis)，ROS 产生和 G2/M 期细胞周期阻滞。此外。Physalin A 可显著提高醌还原酶活性，来提高解毒酶的表达。
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
MedchemExpress Validation 03
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
MedchemExpress Validation 04
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.
MedchemExpress Validation
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.
MedchemExpress Validation
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.
MedchemExpress Validation
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.
MedchemExpress Validation
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.
MedchemExpress Validation
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.
MedchemExpress Validation
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.
MedchemExpress Validation
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.
![Nitrate Reductase (NAD[P]H), Pichia Pastoris (recombinant)](http://hg.y866.cn/biomolecule/lib/file/product_pic/hy-p2996b.gif)
